212 related articles for article (PubMed ID: 1928135)
1. Selecting, developing, and evaluating indicators.
Angaran DM
Am J Hosp Pharm; 1991 Sep; 48(9):1931-7. PubMed ID: 1928135
[TBL] [Abstract][Full Text] [Related]
2. Development of medication-use indicators by the Joint Commission on Accreditation of Healthcare Organizations.
Nadzam DM
Am J Hosp Pharm; 1991 Sep; 48(9):1925-30. PubMed ID: 1928134
[TBL] [Abstract][Full Text] [Related]
3. Quality assurance to quality improvement: measuring and monitoring pharmaceutical care.
Angaran DM
Am J Hosp Pharm; 1991 Sep; 48(9):1901-7. PubMed ID: 1928130
[No Abstract] [Full Text] [Related]
4. Drug usage evaluation: focusing in on topic selection and indicator development.
Thornton JP
Hosp Pharm; 1991 Apr; 26(4):369, 394. PubMed ID: 10110247
[No Abstract] [Full Text] [Related]
5. Quality and outcome: pharmacy's professional imperative.
Enright SM; Flagstad MS
Am J Hosp Pharm; 1991 Sep; 48(9):1908-11. PubMed ID: 1928131
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive drug-use evaluation program in a health maintenance organization.
Cotterell CC; Dombroske L; Fischermann EA
Am J Hosp Pharm; 1991 Aug; 48(8):1712-7. PubMed ID: 1897551
[TBL] [Abstract][Full Text] [Related]
7. Use of generic screening criteria for clinical interventions that link prescribing to credentialing.
Mustion AL; Sobotka J
Hosp Pharm; 1991 Nov; 26(11):968-72, 1015. PubMed ID: 10114824
[TBL] [Abstract][Full Text] [Related]
8. Summary of the final report of the ASHP Quality Assurance Indicators Development Group.
Am J Hosp Pharm; 1992 Sep; 49(9):2246-51. PubMed ID: 1524071
[No Abstract] [Full Text] [Related]
9. The Joint Commission's agenda for change.
Ente BH
Curr Concepts Hosp Pharm Manage; 1989; 11(2):6-14. PubMed ID: 10293152
[TBL] [Abstract][Full Text] [Related]
10. Quality assurance for the JCAHO standards.
Chase PA
Am J Hosp Pharm; 1991 Jul; 48(7):1550-2. PubMed ID: 1882891
[No Abstract] [Full Text] [Related]
11. The integration of quality assessment and a patient-specific intervention/outcomes program.
Mutnick AH; Sterba KJ; Szymusiak-Mutnick BA
Pharm Pract Manag Q; 1998 Jan; 17(4):25-36. PubMed ID: 10174746
[TBL] [Abstract][Full Text] [Related]
12. Quality improvement indicators for hospital/home care pharmacy.
Rich DS
Hosp Pharm; 1993 Oct; 28(10):992, 994-5. PubMed ID: 10129143
[No Abstract] [Full Text] [Related]
13. Designing drug-usage evaluation to meet Joint Commission requirements.
Peroutka JA
Pharm Pract Manag Q; 1996 Jul; 16(2):26-35. PubMed ID: 10161608
[TBL] [Abstract][Full Text] [Related]
14. A mid-sized hospital's experience in indicator data collection.
Melby MJ
Am J Hosp Pharm; 1991 Sep; 48(9):1937-40. PubMed ID: 1928136
[TBL] [Abstract][Full Text] [Related]
15. Development of the Joint Commission's indicators for monitoring the medication use system.
Schaff RL; Schumock GT; Nadzam DM
Hosp Pharm; 1991 Apr; 26(4):326-9, 350. PubMed ID: 10110245
[TBL] [Abstract][Full Text] [Related]
16. Six Sigma: not for the faint of heart.
Benedetto AR
Radiol Manage; 2003; 25(2):40-53. PubMed ID: 12800564
[TBL] [Abstract][Full Text] [Related]
17. Monitoring and evaluation: a 10-step approach to quality assurance.
Hoffmann RP
Hosp Pharm; 1989 Jul; 24(7):546, 548. PubMed ID: 10294144
[No Abstract] [Full Text] [Related]
18. 1988 Joint Commission survey in a community hospital.
Guharoy S; Barajas M; McGalliard J; Aguer T
Hosp Pharm; 1989 Apr; 24(4):287-9. PubMed ID: 10293284
[TBL] [Abstract][Full Text] [Related]
19. The evolving role of the Joint Commission for the Accreditation of Healthcare Organizations.
Schyve PM
Am J Med Qual; 1996; 11(1):S54-7. PubMed ID: 8763236
[TBL] [Abstract][Full Text] [Related]
20. From quality assurance to quality improvement.
Schyve PM; Prevost JA
Psychiatr Clin North Am; 1990 Mar; 13(1):61-71. PubMed ID: 2315206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
